Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension

PURPOSE: To clarify the intraocular pressure (IOP)-lowering effect of a selective prostanoid EP2 receptor agonist, omidenepag isopropyl (OMDI) during a 24-hour period. PATIENTS AND METHODS: Subjects aged ≥20 years and with diagnosed, untreated primary open-angle glaucoma or ocular hypertension were...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiratori, Naka, Nishio, Yusuke, Takeda, Ayaka, Sugimoto, Shio, Takazawa, Kenji, Otsuka, Naomi, Ishida, Naruhiro, Shii, Daisuke, Hori, Kiyotaka, Nakamoto, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500489/
https://www.ncbi.nlm.nih.gov/pubmed/34675468
http://dx.doi.org/10.2147/OPTH.S333042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500489/
https://www.ncbi.nlm.nih.gov/pubmed/34675468
http://dx.doi.org/10.2147/OPTH.S333042

Ejemplares similares